tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
BioMarin price target raised to $60 from $55 at H.C. Wainwright
PremiumThe FlyBioMarin price target raised to $60 from $55 at H.C. Wainwright
18d ago
William Blair views BioMarin acquisition of Amicus as ‘strategic fit’
Premium
The Fly
William Blair views BioMarin acquisition of Amicus as ‘strategic fit’
20d ago
Balanced View on BioMarin’s Amicus Acquisition: Strategic Rare-Disease Upside Versus Near-Term Leverage and Earnings Dilution Supports Hold Rating
Premium
Ratings
Balanced View on BioMarin’s Amicus Acquisition: Strategic Rare-Disease Upside Versus Near-Term Leverage and Earnings Dilution Supports Hold Rating
20d ago
BioMarin rises 16.7%
PremiumThe FlyBioMarin rises 16.7%
21d ago
BioMarin Pharmaceutical (BMRN) and Amicus (FOLD) Stocks Soar on a $5B Acquisition Agreement
Premium
Market News
BioMarin Pharmaceutical (BMRN) and Amicus (FOLD) Stocks Soar on a $5B Acquisition Agreement
21d ago
BioMarin to Acquire Amicus, Expanding Rare Disease Portfolio
Premium
Company Announcements
BioMarin to Acquire Amicus, Expanding Rare Disease Portfolio
21d ago
BioMarin Names New Chief Accounting Officer
PremiumCompany AnnouncementsBioMarin Names New Chief Accounting Officer
22d ago
BioMarin downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
BioMarin downgraded to Market Perform from Outperform at Leerink
1M ago
BioMarin downgraded to Market Perform from Outperform at Leerink
Premium
The Fly
BioMarin downgraded to Market Perform from Outperform at Leerink
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100